Home » Newsletters » BioWorld Science

BioWorld Science

June 7, 2013

View Archived Issues

Several microRNAs elevated in serum after ischemic stroke

Recombinant allergen therapy for patients with birch pollen allergy

CDK4/6 inhibitor LY-2835219: first-in-human study

Genor Biopharma and BioCND to develop biosimilars of Humira and Herceptin

New MR/GR agonists synthesized by Allergan

GS-444217 demonstrates efficacy in model of PAH

AQX-1125 evaluated in patients with asthma

Novel COL8A2 gene mutations found in Korean patients with FECD

Proteostasis Therapeutics receives Michael J. Fox Foundation grant

Genoa Pharmaceuticals's inhaled pirfenidone shows antifibrotic efficacy

Idera begins dosing in phase II IMO-8400 study

Receptos presents update on RPC-1063

Andromeda reports on extension study of the phase III DIA-AID1 trial

Aliskiren and VTP-27999 show different effects of on human renin and prorenin

Positive results obtained from phase III aflibercept study in mCNV

PXS-4728 as a novel SSAO inhibitor with in vivo anti-inflammatory activity

RXi Pharmaceuticals reports results from phase I RXI-109 study

CytomX and Pfizer to develop Probody-Drug Conjugates for cancer

Actelion Pharmaceuticals presents new OX1 receptor antagonists

Novel DNA topoisomerase II inhibitors patented by the University of Colorado

BioLineRx enrolls first patient in phase II BL-8040 study

Lipaglyn obtains approval in India for diabetic dyslipidemia

Sunovion Pharmaceuticals synthesizes new mu opioid receptor agonists

Novel NS5B inhibitors presented for hepatitis C virus infection

RedHill begins patient screening in phase IIa combination therapy for RRMS

Medicago reports interim data from preclinical trial of its H7N9 vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...